⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
GMAB News
Genmab A/S ADS
Transactions with shares and linked securities in Genmab A/S made by managerial employees and their closely associated persons
globenewswire.com
GMAB
Notice to Convene the Annual General Meeting of Genmab A/S
globenewswire.com
GMAB
Genmab Announces Initiation of Share Buy-Back Program
globenewswire.com
GMAB
Genmab Files Annual Report with the U.S. Securities and Exchange Commission
globenewswire.com
GMAB
Genmab Publishes 2025 Annual Report
globenewswire.com
GMAB
HALO
ABBV
MRUS
NVS
JNJ
HRZN
BioNJ Elects Board Officers and Trustees
prnewswire.com
GMAB
MRK
AMTX
JNJ
ASND
ACAD
BMY
PFE
PTC
NVS
SNY
CLDX
CD137 Targeted Therapy Research Report 2026-2030: Market Opportunities, Therapeutic Approaches, Technology Development Platforms & Clinical Trials Insights - ResearchAndMarkets.com
businesswire.com
GMAB
ABL
BNTX
BCRX
$170B Patent Cliff Ignites Biotech Deal Wave: Late-Stage Platforms Command Premium
prnewswire.com
ABBV
ONCY
GMAB
GLSI
ADCT
Grant of Restricted Stock Units and Warrants to Employees in Genmab
globenewswire.com
GMAB
Scancell announces FDA clearance of IND application for global Phase 3 trial of iSCIB1+ in advanced melanoma
globenewswire.com
GMAB